Evidence map›Paper›PMID 40846937›Full record

ArticleJournal of nanobiotechnology2025

Natural multi-active nanoparticles integrated biological hydrogel microcarriers for wound healing.

Junyi Che, Danqing Huang, Yang Wang, Guangtao Gao, Yuanjin Zhao

Abstract read
In one paragraph

Article in Journal of nanobiotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Junyi CheDepartment of Rheumatology and Immunology, School of Biological Science and Medical Engineering, Nanjing Drum Tower Hospital, Southeast University, Nanjing, 210096, China.
Danqing HuangDepartment of Rheumatology and Immunology, School of Biological Science and Medical Engineering, Nanjing Drum Tower Hospital, Southeast University, Nanjing, 210096, China.
Yang WangDepartment of Traditional Chinese Medicine, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, 210023, China.
Guangtao GaoDepartment of Hematology, Nanjing Drum Tower Hospital, Nanjing, 210096, China.
Yuanjin ZhaoDepartment of Rheumatology and Immunology, School of Biological Science and Medical Engineering, Nanjing Drum Tower Hospital, Southeast University, Nanjing, 210096, China. yjzhao@njglyy.com.

Funding

Clinical Trials from Nanjing Drum Tower Hospital 2022-LCYJ-ZD-01Joint Fund of Henan Province Science and Technology R&D Program Project NO.225200810021Key Research & Developement Program of Jiangsu Province BE2022853National Key Research and Development Program of China 2020YFA0908200National Natural Science Foundation of China 32201088National Natural Science Foundation of China T2225003
6 · The paper itself

Abstract

Bioactive substance-integrated hydrogels have demonstrated efficacy in diabetic wound treatment. However, challenges remain in identifying naturally derived, multifunctional active substances capable of addressing the complex pathophysiology of wounds, as well as in tailoring hydrogels to enhance their suitability for wound applications. Here, we present a novel biological hydrogel microcarrier system by integrating Bletilla striata-derived nanoparticles (PdNPs) and polydopamine nanozymes (PDAs) into a hyaluronic acid-methacrylate (HAMA) hydrogel. PdNPs can polarize over-activated macrophages to an anti-inflammatory phenotype and restore fibroblast functionality. Meanwhile, PDAs act as potent reactive oxygen species (ROS) scavengers and protect fibroblasts from oxidative stress-induced apoptosis. When encapsulated into HAMA microcarriers, the PdNP + PDA@HAMA microcarriers significantly accelerate wound healing in a diabetic rat model. These outcomes demonstrate the therapeutic potential of our natural, multifunctional hydrogel microcarriers as a promising wound dressing platform for the treatment of chronic diabetic wounds.

Indexed as

HydrogelsNanoparticlesWound HealingAnimalsApoptosisDiabetes Mellitus, ExperimentalFibroblastsHyaluronic AcidIndolesMacrophagesMaleMethacrylatesMiceOxidative StressPolymersRatsHyaluronic AcidHydrogelsIndolesMethacrylatespolydopaminePolymersReactive Oxygen SpeciesBletilla striataMicrofluidicsNanozymeParticleWound healing

Identifiers

PMID40846937
PMCPMC12372325

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.